The prognostic role of phospho-Src family kinase analysis in tongue cancer

Journal of Cancer Research and Clinical Oncology

Volumn 136, Issue 1, 2010, Pages 27-34

  Ben Izhak, Ofer ^a   Cohen Kaplan, Victoria ^b   Nagler, Rafael M ^b  

^a RAMBAM MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Cancer; Oncogene; Phospho Src family kinase; Prognosis; Tongue; Tumor marker

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROTEIN TYROSINE KINASE;

ADULT; ARTICLE; CANCER GROWTH; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCHEMISTRY; LYMPH NODE METASTASIS; MALE; NICK END LABELING; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE; TONGUE CANCER; TUMOR BIOPSY; TUMOR VOLUME;

AGED; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM STAGING; PHOSPHOPROTEINS; PHOSPHORYLATION; PROGNOSIS; RECEPTOR, ERBB-2; SRC-FAMILY KINASES; TONGUE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TYROSINE;

EID: 71449110267     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-009-0633-1     Document Type: Article

References (41)

1. T Akiyama C Sudo H Ogawara K Toyoshima T Yamamoto 1986 The product of the human C-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity Science 232 1644 1646 10.1126/science.3012781 10.1126/science.3012781 3012781 (Pubitemid 16095607)
2. OP Alho S Kantola U Pirkola E Laara K Jokinen E Pukkala 1999 Cancer of the mobile tongue in Finland-increasing incidence, but improved survival Acta Oncol 38 1021 1024 10.1080/028418699432293 10.1080/028418699432293 10665756
3. O Alper ET Bowden 2005 Novel insights into c-Src Curr Pharm Des 11 1119 1130 10.2174/1381612053507576 10.2174/1381612053507576 15853660 (Pubitemid 40403371)
4. RH Alvarez HM Kantarjian JE Cortes 2006 The role of Src in solid and hematologic malignancies: development of new-generation Src inhibitors Cancer 107 1918 1929 10.1002/cncr.22215 10.1002/cncr.22215 16986126 (Pubitemid 44582963)
5. G Bahar R Feinmesser T Shpitzer A Popovtzer RM Nagler 2007 Salivary analysis in oral cancer patients: DNA and protein oxidation, reactive nitrogen species and antioxidant profile Cancer 101 54 59 10.1002/cncr.22386 10.1002/cncr.22386 (Pubitemid 46120194)
6. O Ben-Izhak F Kablan Z Laster RM Nagler 2005 Oropharyngeal cancer pathogenesis: ubiquitin proteolytic, apoptotic and epidermal growth factor related pathways act in concert-first report Oral Oncol 41 851 860 10.1016/j.oraloncology.2005.04.012 10.1016/j.oraloncology.2005.04.012 16043384 (Pubitemid 41140028)
7. O Ben-Izhak V Kaplan-Cohen N Ilan S Gan I Vlodavsky R Nagler 2006 Heparanase expression in malignant salivary gland tumors inversely correlates with long-term survival Neoplasia 8 879 884 10.1593/neo.06382 10.1593/neo.06382 17032504 (Pubitemid 44564843)
8. O Ben-Izhak Z Laster S Araidy RM Nagler 2007 TUNEL-an efficient prognosis predictor of salivary malignancies Br J Cancer 96 1101 1106 10.1038/sj.bjc.6603655 10.1038/sj.bjc.6603655 17325701 (Pubitemid 46608309)
9. YP Chong KK Ia TD Mulhern HC Cheng 2005 Endogenous and synthetic inhibitors of the Src-family protein tyrosine kinases Biochim Biophys Acta 1754 210 220 16198159
10. WC Conway J Van der Voort van Zyp V Thamilselvan MF Walsh DL Crowe MD Basson 2006 Paxillin modulates squamous cancer cell adhesion and is important in pressure-augmented adhesion J Cell Biochem 98 1507 1516 10.1002/jcb.20819 10.1002/jcb.20819 16552730 (Pubitemid 44141855)
11. SM Dehm K Bonham 2004 SRC gene expression in human cancer: the role of transcriptional activation Biochem Cell Biol 82 263 274 10.1139/o03-077 10.1139/o03-077 15060621 (Pubitemid 38680178)
12. CE Ducker JJ Upson KJ French CD Smith 2005 Two N-myristoyltransferase isozymes play unique roles in protein myristoylation, proliferation and apoptosis Mol Cancer Res 3 463 476 10.1158/1541-7786.MCR-05-0037 10.1158/1541-7786.MCR-05-0037 16123142 (Pubitemid 41232608)
13. CA Finlay PW Hinds TH Tan D Eliyahu M Oren AJ Levine 1988 Activating mutations for transformation by p53 produce a gene product that forms an HSC70-p53 complex with an altered half-life Mol Cell Biol 8 531 539 2832726
14. S Fukuda S Kaga H Sasaki L Zhan L Zhu H Otani R Kalfin DK Das N Maulik 2004 Angiogenic signal triggered by ischemic stress induces myocardial repair in rat during chronic infarction J Mol Cell Cardiol 36 547 549 10.1016/j.yjmcc.2004.02.002 10.1016/j.yjmcc.2004.02.002 15081314 (Pubitemid 38469945)
15. B Grasl-Kraupp B Ruttkay-Nedecky H Koudelka K Bukowska W Bursch R Schulte-Hermann 1995 In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note Hepatology 21 1465 1469 7737654
16. A Hakam Q Fang R Karl D Coppola 2003 Coexpression of IGF-1R and c-Src proteins in human pancreatic ductal adenocarcinoma Dig Dis Sci 48 1972 1978 10.1023/A:1026122421369 10.1023/A:1026122421369 14627343 (Pubitemid 37410086)
17. W Hanna HJ Kahn M Trudeau 1999 Evaluation of HER-2/neu (erbB-2) status in breast cancer: from bench to bedside Mod Pathol 12 827 834 10463486
18. R Ishizawar SJ Parsons 2004 C-Src and cooperating partners in human cancer Cancer Cell 6 209 214 10.1016/j.ccr.2004.09.001 10.1016/j.ccr.2004.09.001 15380511 (Pubitemid 39222033)
19. MS Jackson AA Wrench DS Soutar AG Robertson 1999 Carcinoma of the tongue: the speech therapist's perspective Br J Oral Maxillofac Surg 37 200 204 10.1054/bjom.1999.0032 10.1054/bjom.1999.0032 10454027 (Pubitemid 29348996)
20. S Kantola M Parikka K Jokinen K Hyrynkangs Y Soini OP Alho T Salo 2000 Prognostic factors in tongue cancer-relative importance of demographic, clinical and histopathological factors Br J Cancer 83 614 619 10.1054/bjoc.2000.1323 10.1054/bjoc.2000.1323 10944601
21. H Kim R Chan DL Dankort D Zuo M Najoukas M Park WJ Muller 2005 The c-Src tyrosine kinase associates with the catalytic domain of ErbB-2: implications for ErbB-2 mediated signaling and transformation Oncogene 24 7599 7607 10.1038/sj.onc.1208898 10.1038/sj.onc.1208898 16170374 (Pubitemid 41638034)
22. GS Martin 2004 The road to Src Oncogene 23 7910 7917 10.1038/sj.onc. 1208077 10.1038/sj.onc.1208077 15489909 (Pubitemid 39468850)
23. MF McCarty KI Block 2005 Multifocal angiostatic therapy: an update Integr Cancer Ther 4 301 314 10.1177/1534735405282475 10.1177/1534735405282475 16282507 (Pubitemid 41698179)
24. C Muir L Weiland 1995 Upper aerodigestive tract cancers Cancer 75 147 153 10.1002/1097-0142(19950101)75:1+<147::AID-CNCR2820751304>3.0.CO;2-U 10.1002/1097-0142(19950101)75:1+<147::AID-CNCR2820751304>3.0.CO;2-U 8000993
25. JN Myers T Elkins D Roberts RM Byers 2000 Squamous cell carcinoma of the tongue in young adults: increasing incidence and factors that predict treatment outcomes Otolaryngol Head Neck Surg 122 44 51 10.1016/S0194-5998(00)70142-2 10.1016/S0194-5998(00)70142-2 10629481
26. RM Nagler M Barak H Ben-Aryeh M Peled M Filatov D Laufer 1999 Early diagnostic and treatment monitoring role of Cyfra 21-1 and TPS in oral squamous cell carcinoma Cancer 35 1018 1025 10.1002/(SICI)1097-0142(19990301)85: 5<1018::AID-CNCR2>3.0.CO;2-R 10.1002/(SICI)1097-0142(19990301)85: 5<1018::AID-CNCR2>3.0.CO;2-R (Pubitemid 29115578)
27. RM Nagler H Kerner S Ben-Eliezer I Minkov O Ben-Itzhak 2003 Prognostic role of apoptotic, Bcl-2, c-erbB-2 and p53 tumor markers in salivary gland malignancies Oncology 64 389 398 10.1159/000070298 10.1159/000070298 12759537 (Pubitemid 36682953)
28. R Nagler G Bahar T Shpitzer R Feinmesser 2006 Concomitant analysis of salivary tumor markers-a new diagnostic tool for oral cancer Clin Cancer Res 12 3979 3984 10.1158/1078-0432.CCR-05-2412 10.1158/1078-0432.CCR-05-2412 16818695 (Pubitemid 44078083)
29. R Nagler O Ben-Izhak V Cohen-Kaplan I Shafat I Vlodavsky S Akrish N Ilan 2007 Heparanase up-regulation in tongue cancer: tissue and saliva analysis Cancer 110 2732 2739 10.1002/cncr.23095 10.1002/cncr.23095 17955520 (Pubitemid 350250343)
30. M Nestor T Ekberg J Dring GA van Dongen K Wester V Tolmachev M Anniko 2007 Quantification of CD44v6 and EGFR expression in head and neck squamous cell carcinomas using a single-dose radioimmunoassay Tumour Biol 28 253 263 10.1159/000110898 10.1159/000110898 17992053 (Pubitemid 350165831)
31. N Quenel J Wafflart F Bonichon I de Mascarel M Trojani M Durand A Avril JM Coindre 1995 The prognostic value of C-erbB-2 in primary breast carcinoma: a study of 942 cases Breast Cancer Res Treat 35 283 291 10.1007/BF00665980 10.1007/BF00665980 7579499
32. KC Ribeiro LP Kowalski MR Latorre 2000 Impact of comorbidity, symptoms, and patients' characteristics on the prognosis of oral carcinomas Arch Otolaryngol Head Neck Surg 126 1079 1085 10979120
33. T Shpitzer G Bahar R Feinmesser RM Nagler 2007 A comprehensive salivary analysis for oral cancer diagnosis J Cancer Res Clin Oncol 133 613 617 10.1007/s00432-007-0207-z 10.1007/s00432-007-0207-z 17479291 (Pubitemid 47077052)
34. I Tamura T Sakaki B Chaqour PS Howard T Ikeo EJ Macarak 2003 Correlation of P-cadherin and beta-catenin expression and phosphorylation with carcinogenesis in rat tongue cancer induced with 4-nitroquinoline 1-oxide Oral Oncol 39 506 514 10.1016/S1368-8375(03)00013-7 10.1016/S1368-8375(03)00013-7 12747976 (Pubitemid 36579119)
35. RK Vadlamudi AA Sahin L Adam RA Wang R Kumar 2003 Heregulin and HER2 signaling selectively activates c-Src phosphorylation at tyrosine 215 FEBS Lett 543 1-3 76 80 10.1016/S0014-5793(03)00404-6 10.1016/S0014-5793(03)00404-6 12753909 (Pubitemid 36577231)
36. M Warmuth R Damoiseaux Y Liu D Fabbro N Gray 2003 SRC family kinases: potential targets for the treatment of human cancer and leukemia Curr Pharm Des 9 2043 2059 10.2174/1381612033454126 10.2174/1381612033454126 14529415 (Pubitemid 37139082)
37. GR Wilson A Cramer A Welman F Knox R Swindell H Kawakatsu RB Clarke C Dive NJ Bundred 2006 Activated c-SRC in ductal carcinoma in situ correlates with high tumour grade, high proliferation and HER2 positivity Br J Cancer 95 1410 1414 10.1038/sj.bjc.6603444 10.1038/sj.bjc.6603444 17060931 (Pubitemid 44760094)
38. JM Wood G Bold E Buchdunger R Cozens S Ferrari J Frei F Hofmann J Mestan H Mett T O'Reilly E Persohn J Rosel C Schnell D Stover A Theuer H Towbin F Wenger K Woods-Cook A Menrad G Siemeister M Schirner KH Thierauch MR Schneider J Drevs G Martiny-Baron F Totzke 2000 PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration Cancer Res 60 2178 2189 10786682 (Pubitemid 30225181)
39. AH Wyllie CO Bellamy VJ Bubb AR Clarke S Corbet L Curtis DJ Harrison ML Hooper N Toft S Webb CC Bird 1999 Apoptosis and carcinogenesis Br J Cancer 80 Suppl 1 34 37 10466759
40. BB Yeole R Sankaranarayanan M Sunny L Sc R Swaminathan DM Parkin 2000 Survival from head and neck cancer in Mumbai (Bombay), India Cancer 89 437 444 10.1002/1097-0142(20000715)89:2<437::AID-CNCR32>3.0.CO;2-R 10.1002/1097-0142(20000715)89:2<437::AID-CNCR32>3.0.CO;2-R 10918177 (Pubitemid 30489895)
41. A Zetser Y Bashenko E Edovitsky F Levy-Adam I Vlodavsky N Ilan 2006 Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation Cancer Res 66 1455 1463 10.1158/0008-5472.CAN-05-1811 10.1158/0008-5472.CAN-05-1811 16452201 (Pubitemid 43259926)